Project Grant R41DA050225

The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $959,964 Project Grant to Charles River Analytics, Inc. to design and demonstrate the feasibility of a prototype system called "Stimulant Use Recovery via Immersive Virtual Environments (SURVIVE)" for the treatment of stimulant use disorder (STUD). The goal of SURVIVE is to leverage virtual reality technology to provide a convenient and engaging means of delivering...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $618,932 Project Grant (CFDA 93.273 - Alcohol Research Programs) to Brown University to develop a virtual reality (VR) experience that can be used as part of brief motivational interventions (BMIs) to help reduce heavy drinking among young adults. The goal is to use the VR experience to enhance client engagement and elicit change talk in MI-based interventions by helping participants reflect more deeply on the discrepancy...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop and evaluate a customized version of the "MyTrials" remote biomarker capture system for use in decentralized clinical trials (DCTs) for substance use disorders (SUDs). The key products and services to be delivered include: 1) Refinement of the existing MyTrials prototype to support the...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to validate a virtual reality-based attentional bias (VR-AB) marker as a biomarker for tobacco use disorder. The $1,766,843 project will assess 200 daily tobacco users on the VR nicotine cue exposure paradigm, then pseudo-randomize them to receive either varenicline or placebo. The study will evaluate the VR-AB marker's reliability, its potential as...

The National Institute on Drug Abuse (NIDA) awarded a $643,978 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to See Yourself Health LLC, a woman-owned small business in Beverly, MA. The grant will fund the development of the CHIRON PROJECT, an immersive virtual reality platform that aims to address workplace stress and burnout among healthcare workers. The project's goals are to build the SYH Immersive World platform using virtual reality and WebXR gaming...

The National Science Foundation (NSF) Division of Information and Intelligent Systems awarded a $162,827 Project Grant to the University of Wisconsin - Madison, through the University of Wisconsin System, to develop an "Intelligent Pervasive Augmented Reality Therapy (IPAL)" system for managing opioid use disorder (OUD) and addiction. The 1-year project will integrate complementary psychotherapies like cognitive behavioral therapy and heart rate variability biofeedback with immersive...

This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $254,892 to Ralphvr Inc. to develop a virtual reality (VR) application called "Virtual Partner" to reduce delirium in intensive care unit (ICU) patients. The key objectives of the award are to: 1) obtain feedback from ICU staff and former ICU patients to inform the VR application...

The National Institute of Mental Health (NIMH) awarded a $449,729 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Openmindxr LLC, a for-profit limited liability company located in Carmel, Indiana. The grant will fund the development and testing of a suite of virtual reality (VR) programs to address social skills deficits in children aged 9-15 with ADHD. The VR programs will consist of three modules: PerspectivR to improve perspective-taking, Social Skills Challenge...

This federal Project Grant award of $426,234, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to refine and test a novel virtual reality (VR) parent training tool for caregivers of children with autism spectrum disorder (ASD) who exhibit severe destructive behavior. The key products and services to be delivered include: 1) Developing a customizable, in-home VR training...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $1,002,000 to Cedars-Sinai Medical Center to conduct a pilot randomized controlled trial (RCT) testing the clinical impact and feasibility of a virtual reality (VR) cognitive behavioral therapy (CBT) program for patients with irritable bowel syndrome (IBS). The 8-week VR CBT program, called IBS/VR, was developed...